Loading
A UK neuroblastoma charity that funds clinical research, supports families and helps children reach treatments not yet available in the UK.
Solving Kids' Cancer UK began in 2006 as the 2Simple Trust, supporting the parents of a boy named Jack in raising money for treatment abroad after UK options ran out. From 2009 other families joined to fundraise for anti-GD2 antibody therapy in the United States and Germany, then not available in the UK, and between 2011 and 2015 the charity took its present name. It now initiates and funds clinical research on neuroblastoma, runs a professional family support service and shares current treatment information with parents. The Charity Commission register records latest income of about £2.9 million for the year ending 31 March 2025.
Shares Neuroblastoma (paediatric) and the tag uk.
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/